Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Expanded G4C2 repeats derived from mutations of the C9orf72 gene are causative factors in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, leading to multiple pathological events. Bis thiophene para dinicotinimidamide 2a was reported to preferentially stabilize G-quadruplex G4C2 RNA structures at sub-micromolar concentrations. We replaced its amidine groups with BBB-compliant guanyl hydrazones, and carried out scaffold variations to improve water solubility. An eight-membered array was built around bis-thiophene- (4b-6a), bis-oxazole- (7b), diphenylurea diamide- (8b) and phenyldioxy ditriazolephenyl scaffolds (9a,b). Biological profiling of the array identified 4b as a promising, drug-like hit, active in cellular assays on ALS patient-derived cells.

More information Original publication

DOI

10.1016/j.ejmech.2025.117736

Type

Journal article

Publication Date

2025-09-05T00:00:00+00:00

Volume

293

Keywords

ALS, C9orf72 gene, Expanded G(4)C(2) repeats, Guanyl hydrazones, NMR binding studies, RNA transcripts, RNA-Small molecule modeling, Humans, C9orf72 Protein, Drug Design, Hydrazones, RNA, Structure-Activity Relationship, G-Quadruplexes, Molecular Structure, Dose-Response Relationship, Drug, Amyotrophic Lateral Sclerosis